Literature DB >> 17662236

How lipids influence the mode of action of membrane-active peptides.

E Sevcsik1, G Pabst, A Jilek, K Lohner.   

Abstract

The human, multifunctional peptide LL-37 causes membrane disruption by distinctly different mechanisms strongly dependent on the nature of the membrane lipid composition, varying not only with lipid headgroup charge but also with hydrocarbon chain length. Specifically, LL-37 induces a peptide-associated quasi-interdigitated phase in negatively charged phosphatidylglycerol (PG) model membranes, where the hydrocarbon chains are shielded from water by the peptide. In turn, LL-37 leads to a disintegration of the lamellar organization of zwitterionic dipalmitoyl-phosphatidylcholine (DPPC) into disk-like micelles. Interestingly, interdigitation was also observed for the longer-chain C18 and C20 PCs. This dual behavior of LL-37 can be attributed to a balance between electrostatic interactions reflected in different penetration depths of the peptide and hydrocarbon chain length. Thus, our observations indicate that there is a tight coupling between the peptide properties and those of the lipid bilayer, which needs to be considered in studies of lipid/peptide interaction. Very similar effects were also observed for melittin and the frog skin peptide PGLa. Therefore, we propose a phase diagram showing different lipid/peptide arrangements as a function of hydrocarbon chain length and LL-37 concentration and suggest that this phase diagram is generally applicable to membrane-active peptides localized parallel to the membrane surface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662236     DOI: 10.1016/j.bbamem.2007.06.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

Review 1.  Use of X-ray scattering to aid the design and delivery of membrane-active drugs.

Authors:  G Pabst; D Zweytick; R Prassl; K Lohner
Journal:  Eur Biophys J       Date:  2012-06-02       Impact factor: 1.733

Review 2.  Fluorescence spectroscopy and molecular dynamics simulations in studies on the mechanism of membrane destabilization by antimicrobial peptides.

Authors:  Gianfranco Bocchinfuso; Sara Bobone; Claudia Mazzuca; Antonio Palleschi; Lorenzo Stella
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

3.  Interdigitation of Lipids Induced by Membrane-Active Proteins.

Authors:  T Devanand; Sankaran Krishnaswamy; Satyavani Vemparala
Journal:  J Membr Biol       Date:  2019-06-11       Impact factor: 1.843

4.  Cholesterol modulates the membrane effects and spatial organization of membrane-penetrating ligands for G-protein coupled receptors.

Authors:  George Khelashvili; Sayan Mondal; Olaf S Andersen; Harel Weinstein
Journal:  J Phys Chem B       Date:  2010-09-23       Impact factor: 2.991

Review 5.  The lipid network.

Authors:  Marc-Antoine Sani; Frances Separovic; John D Gehman
Journal:  Biophys Rev       Date:  2012-03-24

Review 6.  High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

Authors:  Guangshun Wang; Biswajit Mishra; Raquel F Epand; Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2014-01-23

7.  Membrane thickening by the antimicrobial peptide PGLa.

Authors:  Georg Pabst; Stephan L Grage; Sabine Danner-Pongratz; Weiguo Jing; Anne S Ulrich; Anthony Watts; Karl Lohner; Andrea Hickel
Journal:  Biophys J       Date:  2008-10-03       Impact factor: 4.033

Review 8.  The role of antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ophthalmic Res       Date:  2008-12-20       Impact factor: 2.892

9.  A comparative study on the interactions of SMAP-29 with lipid monolayers.

Authors:  Frances Neville; Andrey Ivankin; Oleg Konovalov; David Gidalevitz
Journal:  Biochim Biophys Acta       Date:  2009-10-02

10.  Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix.

Authors:  E Sevcsik; G Pabst; W Richter; S Danner; H Amenitsch; K Lohner
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.